Ask AI
ProCE Banner Series

Future in Focus: Emerging Opportunities for Novel Immunotherapy Combinations in Upper Gastrointestinal Cancers

Join us for this interactive, CME/EBAC-certified live webinar featuring global expert perspectives on novel immunotherapy strategies for advanced upper GI cancers, with a focus on recent practice-changing studies, including ESMO presentations. Be sure to bring your questions for the live Q&A session with the expert panel. 

  AMA
  | EBAC®
Who Should Attend

This activity is intended for oncologists and other healthcare professionals caring for patients with upper gastrointestinal cancers.

All Events

Future in Focus: Emerging Opportunities for Novel Immunotherapy Combinations in Upper Gastrointestinal Cancers

Upcoming Events

November

14

2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Gastrointestinal cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in optimally applying immunotherapy combination regimens based on recent data and practice-changing findings in managing patients with upper gastrointestinal cancers.

Target Audience
This activity is intended for oncologists and other healthcare professionals caring for patients with upper gastrointestinal cancers.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Appraise new efficacy and safety data on novel immunotherapy combinations in advanced upper gastrointestinal cancers and the potential implications for clinical practice

  • Evaluate how the mechanism of action, molecular targets, and design of investigational immunotherapy combinations impact safety and efficacy in patients with advanced upper gastrointestinal cancers

  • Plan first-line treatments that incorporate approved or investigational immunotherapy combinations available through clinical trials to optimize outcomes for patients with advanced upper gastrointestinal cancers

  • Implement strategies to support equitable access to novel immunotherapy combinations in underserved patient populations with advanced upper gastrointestinal cancers

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EBAC® Accreditation

Clinical Care Options, LLC is an EBAC® accredited provider since 2025

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/65f35ab16f6ca.png

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hour of effective education time.

EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191